Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - HeartWare International, Inc.c92016exv99w1.htm
Washington, D.C. 20549
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 4, 2009
(Exact name of registrant as specified in its charter)
Delaware   001-34256   26-3636023
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer Identification No.)
205 Newbury Street, Suite 101
Framingham, MA
(Address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code: 508.739.0950
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 2.02 Results of Operations and Financial Condition
On November 4, 2009, HeartWare International, Inc. (the “Company”) issued a press release announcing financial results for the third quarter ended September 30, 2009. A copy of the release is furnished with this report as Exhibit 99.1.
The information in this Current Report on Form 8-K and the Exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.
Item 9.01 Financial Statements and Exhibits
Exhibit No.   Description
Press Release issued by HeartWare International, Inc. dated November 4, 2009.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    HeartWare International, Inc.    
Date: November 4, 2009   By:   /s/ David McIntyre    
      Name:   David McIntyre    
      Title:   Chief Financial Officer and    
          Chief Operating Officer